MARKET

BPMC

BPMC

Blueprint Medicines Corp
NASDAQ
88.51
+0.85
+0.97%
Pre Market: 88.01 -0.5 -0.56% 05:11 04/29 EDT
OPEN
86.34
PREV CLOSE
87.66
HIGH
89.19
LOW
85.70
VOLUME
20
TURNOVER
77.38M
52 WEEK HIGH
121.90
52 WEEK LOW
73.04
MARKET CAP
5.72B
P/E (TTM)
-82.9289
1D
5D
1M
3M
1Y
5Y
1D
What Analysts Are Saying About Blueprint Medicines Stock
Benzinga · 12h ago
Blueprint Medicines Price Target Cut to $130.00/Share From $133.00 by Needham
Dow Jones · 15h ago
Blueprint Medicines Is Maintained at Buy by Needham
Dow Jones · 15h ago
Needham Maintains Buy on Blueprint Medicines, Lowers Price Target to $130
Benzinga · 15h ago
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
NASDAQ · 19h ago
Blueprint Medicines price target lowered to $130 from $133 at Needham
TipRanks · 21h ago
BLUEPRINT MEDICINES CORP <BPMC.O>: NEEDHAM CUTS TARGET PRICE TO $130 FROM $133
Reuters · 21h ago
Positive Outlook for Blueprint Medicines Amid Market Challenges: Buy Rating Affirmed
TipRanks · 22h ago
More
About BPMC
More
Blueprint Medicines Corporation is a fully integrated, commercial-stage, global biopharmaceutical company. The Company invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and PDGFRA Exon 18 mutant GIST in the United States and Europe. It has a pipeline of research and development programs that range from early science to advanced clinical trials in mast cell-mediated diseases, including systemic mastocytosis (SM) and chronic urticaria, breast cancer, and other solid tumors vulnerable to CDK2 inhibition. Its pipeline includes Elenestinib (BLU-263), BLU-808, and BLU-956. It is developing Elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders. It is advancing BLU-808, a potent and selective wild-type KIT inhibitor, for mast cell diseases.
Recently
Symbol
Price
%Change

Webull offers Blueprint Medicines Corp stock information, including NASDAQ: BPMC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BPMC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BPMC stock methods without spending real money on the virtual paper trading platform.